CasNo.149107-86-8,Docetaxel 2',7,10-Tris(triethylsilyl) Ether,[4-Acetyloxy-1-hydroxy-10,14,17,17-tetramethyl-15-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenyl-2-triethylsilyloxypropanoyl]oxy-11-oxo-9,12-bis(triethylsilyloxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate(149107-86-8) Suppliers

0	Negotiable

Min.Order :0
Purity: ≥95%

Keywords

2',7,10-Tris(triethylsilyl)docetaxel [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-[(triethylsilyl)oxy]-benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,...

Quick Details

Appearance:White Solid
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store at 2-8°C under inert atmosphere
Transportation:

Superiority:

We provide customized and high-quality Docetaxel 2',7,10-Tris(triethylsilyl) Ether product for your project.

Details:

Docetaxel 2',7,10-Tris(triethylsilyl) Ether is a derivative of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer.